Fibroblast-conditioned medium
Fibroblast-conditioned medium has been studied in 2 papers since 2018: 1 observational study in people, 1 in cells; 1 in the past year. The newest paper, Nov 12, 2026: “Multi-omics and Machine Learning Identify Senescence Targets Linked to CXCL12–CXCR4 T-Cell Responses in Periodontitis”.
2 papers study it1 findingUpdated
1 new paper in 30 daysSee all 2 papers on fibroblast-conditioned medium
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
- 1 lab in 1 country
- Funders: Ministerstvo Školství, Mládeže a Tělovýchovy and 1 more
- Humans1
- Cells1
What did studies of fibroblast-conditioned medium find?
1Studies of fibroblast-conditioned medium measured one outcome, DNMT1 degradation.
DNMT1 degradation
downin cells1
1 study
DNMT1 degradation
downin cells1
Fibroblast-conditioned medium inhibits DNMT1 degradation in cells (decitabine treatment).
“abrogated DAC effect on degradation of DNA methyltransferase 1.”
Cellsdecitabine treatmentconditioned medium from senescent fibroblastscolorectal cancer cell
Stem cells international